Molecular and Cellular Pharmacology
Published by STEM/CS Media (Journal Finder)
eISSN : 1938-1247
Abbreviation : Mol. Cell. Pharmacol.
Aims & Scope
Molecular and Cellular Pharmacology publishes Original Research Articles, Reviews and PharmSights in all areas broadly related to Pharmacological Sciences.
Manuscripts undergo peer-review.
The target audience includes scientists and clinicians engaged in basic, clinical and translational research.
Areas of focus include, but not limited to: -molecular and cellular basis of drug actions including effects of pharmacological agents on gene regulation, chromosome structure and dynamics, protein function and modification, signal transduction, cell death and survival, and intracellular trafficking- drug design and discovery- pharmacogenomics and pharmacoproteomics- clinical pharmacology including pharmacokinetics, pharmacodynamics, pathways of drug metabolism, and drug-drug interactions- immunopharmacology including immunotherapy, immunotoxicology, and immunopathology- toxicology including toxicokinetics and toxicodynamics- radiopharmacology including radiopharmaceuticals, novel imaging agents, and radiation and drug interactions
View Aims & ScopeMetrics & Ranking
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.278 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q3 |
h-index
| Year | Value |
|---|---|
| 2024 | 28 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 17403 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 6 |
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
